GlobalData provides unique and market-leading data and insights into the genitourinary disorders market. Browse or search our Report Store for the latest comprehensive reports, market data, analysis and survey findings alongside industry information on key companies, markets and financial deals.

Duchenne Muscular Dystrophy – Opportunity Assessment and Forecast to 2030

  • $6,995
  • December 2021
Duchenne muscular dystrophy (DMD) is a rare genetic disorder characterized by progressive muscle degeneration and weakness due to the alterations of a protein called dystrophin. Dystrophin is part of a...

Overactive Bladder: Global Drug Forecast and Market Analysis to 2030

  • $10,995
  • December 2021
The term ‘overactive bladder’ or ‘OAB’ was first coined in 1997 and is currently defined as “urinary urgency, usually accompanied by increased daytime frequency and/or nocturia, with urinary incontinence (OAB-wet)...

Fragile X Syndrome – Global Clinical Trials Review, H2, 2021

  • $2,500
  • November 2021
GlobalData's clinical trial report, “Fragile X Syndrome - Global Clinical Trials Review, H2, 2021" provides an overview of Fragile X Syndrome Clinical trials scenario. This report provides top line data...

Down Syndrome – Global Clinical Trials Review, H2, 2021

  • $2,500
  • November 2021
GlobalData's clinical trial report, “Down Syndrome - Global Clinical Trials Review, H2, 2021" provides an overview of Down Syndrome Clinical trials scenario. This report provides top line data relating to...

Mucopolysaccharidosis I (MPS I) (Hurler Syndrome ) – Global Clinical Trials Review, H2, 2021

  • $2,500
  • November 2021
GlobalData's clinical trial report, “Mucopolysaccharidosis I (MPS I) (Hurler Syndrome ) - Global Clinical Trials Review, H2, 2021" provides an overview of Mucopolysaccharidosis I (MPS I) (Hurler Syndrome ) Clinical...

Duchenne Muscular Dystrophy – Global Clinical Trials Review, H2, 2021

  • $2,500
  • November 2021
GlobalData's clinical trial report, “Duchenne Muscular Dystrophy - Global Clinical Trials Review, H2, 2021" provides an overview of Duchenne Muscular Dystrophy Clinical trials scenario. This report provides top line data...

Prader-Willi Syndrome (PWS) – Global Clinical Trials Review, H2, 2021

  • $2,500
  • November 2021
GlobalData's clinical trial report, “Prader-Willi Syndrome (PWS) - Global Clinical Trials Review, H2, 2021" provides an overview of Prader-Willi Syndrome (PWS) Clinical trials scenario. This report provides top line data...

Kidney Disease (Nephropathy) – Global Clinical Trials Review, H2, 2021

  • $2,500
  • October 2021
GlobalData's clinical trial report, “Kidney Disease (Nephropathy) - Global Clinical Trials Review, H2, 2021" provides an overview of Kidney Disease (Nephropathy) Clinical trials scenario. This report provides top line data...

Marfan Syndrome – Global Clinical Trials Review, H2, 2021

  • $2,500
  • October 2021
GlobalData's clinical trial report, “Marfan Syndrome - Global Clinical Trials Review, H2, 2021" provides an overview of Marfan Syndrome Clinical trials scenario. This report provides top line data relating to...

IgA Nephropathy (Berger’s Disease) – Global Clinical Trials Review, H2, 2021

  • $2,500
  • September 2021
GlobalData's clinical trial report, “IgA Nephropathy (Berger's Disease) - Global Clinical Trials Review, H2, 2021" provides an overview of IgA Nephropathy (Berger's Disease) Clinical trials scenario. This report provides top...